MetaCap

Korro Bio (KRRO) vs Nature's Sunshine Products (NATR)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Korro Bio (KRRO) has outperformed Nature's Sunshine Products (NATR) over the past year, gaining 93.9% versus a loss of 51.8%. Over five years, NATR leads with a -40.4% price change compared with -95.7% for KRRO. Nature's Sunshine Products is the larger company by market cap ($176.4 million vs $167.2 million), about 1.1 times the size, while Korro Bio is growing revenue faster (+181.5% vs +5.7%).

Nature's Sunshine Products converts more of its revenue into profit, with a net margin of 4.1% versus -1834.5%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

KRRO+93.95%NATR-51.84%
+175%+56%-63%
Nov 21, 20251 yearNov 20, 2026
KRRO-95.95%NATR-44.52%
+58%-24%-106%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

KRRO versus NATR key metrics
MetricKRRONATR
Share price$12.18$10.18
Market cap$167.18M$176.41M
1-day change-0.08%+0.10%
YTD return+52.06%-52.83%
1-year return+93.95%-51.84%
5-year return-95.67%-40.40%
P/E ratio (TTM)—12.41
Forward P/E—10.77
EPS (TTM)$-8.89$0.82
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$6.39M$480.14M
Revenue growth (YoY)+181.46%+5.67%
Net income (latest FY)$-117.26M$19.52M
Gross margin—72.42%
Operating margin-1906.37%5.15%
Net margin-1834.48%4.07%
52-week high$17.35$28.14
52-week low$5.20$9.38
Distance from 52-week high-29.81%-63.82%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+76.52%+62.08%
Average volume186.03K168.24K
Shares outstanding13.73M17.33M
Employees58806
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • KRRO has outperformed NATR by 145.8 percentage points over the past year.
  • Nature's Sunshine Products is more profitable, keeping 4.1 cents of every revenue dollar as net income versus -1834.5 cents for Korro Bio.
  • Korro Bio grew revenue faster in its latest fiscal year (+181.46% vs +5.67%).

About Korro Bio

KRRO stock →

Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States. The company's lead product candidate is KRRO-121 for the treatment for hyperammonemia.

Health Care · Biotechnology: Pharmaceutical Preparations · 58 employees

About Nature's Sunshine Products

NATR stock →

Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision; and immune products to support and strengthen the human immune system.

Health Care · Biotechnology: Pharmaceutical Preparations · 806 employees

KRRO vs NATR FAQ

Which is bigger, Korro Bio or Nature's Sunshine Products?

Nature's Sunshine Products (NATR) is larger, with a market capitalization of $176.41M compared with $167.18M for Korro Bio (KRRO).

Which stock has performed better over the past year, KRRO or NATR?

KRRO returned +93.95% over the past 12 months, compared with -51.84% for NATR (price return, excluding dividends). Past performance does not predict future results.

Are Korro Bio and Nature's Sunshine Products in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons